White paper

We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.

Beyond Jeito Capital’s in-depth market analysis, this paper features valuable insights from industry leaders, including Paul Hudson (CEO of Sanofi), Christophe Weber (President & CEO of Takeda), Dr. Aradhana Sarin (Group CFO of AstraZeneca), and Pascal Touchon (Chairman of the Board of Atara Biotherapeutics), who share their perspectives on the future of biopharma and its role in addressing healthcare challenges.